Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
How has the chronic pain market grown in recent years?
The market size for chronic pain has seen a robust growth in the past few years. The market which was valued at $78.79 billion in 2024 is set to increase to $84.96 billion in 2025, growing at a compounded annual growth rate (CAGR) of 7.8%. The notable growth during the historic period was largely due to factors such as injury and trauma, surgery procedures, inflammatory conditions, nerve damage and neuropathy, and a lack of efficient treatments.
How is the chronic pain market size expected to evolve during the forecast period?
In the coming years, the market for chronic pain is anticipated to exhibit robust growth. It’s projected to expand to $117.74 billion by 2029, with a compound annual growth rate (CAGR) of 8.5%. This growth during the forecasted period could be attributed to various factors such as the aging populace, the development of telemedicine, increased public health consciousness, advancements in genetic research and precision medicine, and psychosocial stressors. Some key trends in this forecast period include the incorporation of wearable tech devices, educational programs about pain and accompanying support groups, comprehensive pain management strategies, non-opioid alternatives for pain management, and the emerging field of regenerative medicine for pain management.
Get your chronic pain market report here!
https://www.thebusinessresearchcompany.com/report/chronic-pain-global-market-report
Which key drivers are propelling the chronic pain market’s growth?
The chronic pain market is forecasted to flourish due to the increasing number of individuals suffering from persistent pain, sometimes lasting beyond the standard healing period or for a duration typically longer than three months. The rise in chronic pain sufferers propels the growth of this market as the escalating need for effective pain management strategies – encompassing pharmaceuticals and medical devices – spawns opportunities for industry innovation and expansion. For example, data from the Australian Institute of Health and Welfare indicates that in June 2024, approximately 4.0 million Australians, or 16% of the population, were contending with back issues in 2022. Within a year, these back issues emerged as the third highest disease burden, accounting for 4.3% of the country’s overall disease burden. Concurrently, a report issued by the Institute for Health Metrics and Evaluation in February 2024 predicts that global neck pain cases could surge to 269 million by 2050 (ranging between 219 and 322 million), a 32.5% increase (ranging between 23.9% and 42.3%) from 2020’s figures. Consequently, the increasing incidence of chronic pain sufferers is stimulating the growth of the chronic pain market.
What are the market segments in the chronic pain industry?
The chronic pain market covered in this report is segmented –
1) By Product: Drug, Devices
2) By Indication: Neuropathic Pain, Arthritis Pain, Chronic Back Pain, Cancer Pain, Migraine, Fibromyalgia, Other Indications
3) By End User: Hospitals, Clinics, Research Organization
Subsegments:
1) By Drug: Non-Opioid Analgesics, Opioids, Antidepressants, Anticonvulsants, Topical Analgesics, Corticosteroids
2) By Devices: Transcutaneous Electrical Nerve Stimulation (TENS) Units, Spinal Cord Stimulators, Intrathecal Drug Delivery Systems, Heat And Cold Therapy Devices, Bioelectronic Devices
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=11970&type=smp
Which leading companies are shaping the growth of the chronic pain market?
Major companies operating in the chronic pain market include Pfizer Inc., Johnson & Johnson, AbbVie Inc., Novartis AG, Sanofi S.A., Bristol-Myers Squibb Company, Abbott Laboratories, Mitsubishi Chemical Group Corporation, GlaxoSmithKline plc., Eli Lilly and Company, AstraZeneca plc., Becton, Dickinson, and Company, Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Biogen Inc., Endo International plc., Noven Pharmaceuticals Inc., Anika Therapeutics Inc., Collegium Pharmaceutical Inc., Heron Therapeutics Inc., Paradigm Biopharmaceuticals Ltd., Braeburn Inc., Taiwan Liposome Company Ltd., Axial Healthcare, AcelRx Pharmaceuticals Inc., Centrexion Therapeutics Corp., Vertanical GmbH, IKI Health Group, Tonix Pharmaceuticals Inc., Paperplane Therapeutics
What key trends are currently impacting the chronic pain market’s development?
The rise of alternative methods for managing pain is a top trend being seen in the chronic pain market. Firms within this sector are concentrating on the creation of cutting-edge, easy-to-use nerve stimulation instruments that use electric pulses to trigger nerves and alleviate pain, offering a non-invasive pain relief option to maintain their standing within the market. As an illustration, Abbott Laboratories, a healthcare firm based in the USA working on diagnostic tools, medical devices, nutrition, and branded generic drugs, launched Eterna in December 2022. Eterna is a high-tech spinal cord stimulation (SCS) system and is currently the smallest implantable and rechargeable device accessible in the chronic pain treatment market. Abbott’s proprietary low-dose BurstDR stimulation, the only waveform technology with significant clinical evidence (1A evidence), is utilized by the Eterna SCS, which has shown to reduce pain by 23% more than traditional waveform technology approaches.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=11970
Which geographic areas are influencing the growth of the chronic pain market?
North America was the largest region in the chronic pain market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the chronic pain market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Similar Reports By The Business Research Company:
Aerospace Bearings Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/aerospace-bearings-global-market-report
Aerospace And Defense Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/aerospace-defense-global-market-report
Vanadium Ore Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/vanadium-ore-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
